Pazopanib plus cetuximab in recurrent or metastatic head and neck squamous cell carcinoma: an open-label, phase 1b and expansion study.
暂无分享,去创建一个
K. Trinkaus | B. Siegel | P. Oppelt | D. Adkins | M. Siegel | F. Dehdashti | J. Ley | Xuntian Jiang | N. N. Salama | P. Mehan